Drugs linked to poor outcomes in older people with Alzheimer's disease

(Medical Xpress)—Exposure to high-risk drug classes is associated with higher rates of hospitalisation and mortality in older people with Alzheimer's disease, research by the University of Sydney has found.

The research paper, published in PLOS ONE journal, was authored by Dr Danijela Gnjidic, Lecturer and NHMRC Early Career Fellow from the Faculty of Pharmacy at University of Sydney.

Dr Gnijdic said that with and without Alzheimer's disease that are treated with high-risk classes, including a range of sedative and anticholinergic drugs, are more likely to be hospitalised and die than older people not treated with these drugs.

"The study revealed that increased cumulative exposure to anticholinergic and sedative drugs was associated with higher rates of hospitalisation and over one year in both people with and without Alzheimer's disease," Dr Gnjidic said.

"We found that 51% of people with Alzheimer's disease were exposed to drugs with anticholinergic and sedative effects, compared to 33% people without Alzheimer's disease."

Anticholinergic drugs are commonly used to treat asthma, incontinence, gastrointestinal cramps, and muscular spasms, and sedative drugs are prescribed for depression and sleep disorders.

"The study adds to the growing international body of evidence that the drug side-effects are a leading cause of preventable hospitalisation among older people," Dr Gnjidic said.

"Population-based research suggests that older people continue to take drugs with an unfavorable risk to benefit ratio.

"The study highlights the need for health practitioners and consumers to work together to implement evidence-based strategies to prevent and detect drug-related problems, particularly in older people with Alzheimer's disease," she said.

More information: Gnjidic D, Hilmer SN, Hartikainen S, Tolppanen A-M, Taipale H, et al. (2014) Impact of High Risk Drug Use on Hospitalization and Mortality in Older People with and without Alzheimer's Disease: A National Population Cohort Study. PLoS ONE 9(1): e83224. DOI: 10.1371/journal.pone.0083224

Related Stories

Many Alzheimer's patients get drugs with opposing effects

date Oct 25, 2011

You wouldn't brake your car while stepping on the gas—or wash down a sleeping pill with espresso. Yet many people taking common Alzheimer's disease medications—cholinesterase inhibitors—are given medications ...

Recommended for you

Volunteers in Tunisia develop app for Alzheimer's patients

date 6 hours ago

About a year ago, Azer Jaafoura and a few of his colleagues at Samsung Electronics Tunisia (SETN) were thinking of helping out Alzheimer's patients. However, with a full-time job and already volunteering at a children's hospital, ...

Helpful app for people with dementia

date Apr 21, 2015

Bangor University is providing expertise to support the development and effectiveness of 'Book of You', an 'app' being welcomed as having the potential to revolutionise reminiscence therapy for people with dementia.

New approaches for early diagnosis of Alzheimer's

date Apr 17, 2015

Mild cognitive impairment, or MCI, may be one of Alzheimer's earliest signs. The subtle changes of MCI include problems with memory, language, thinking and judgment and a subjective sense that mental function ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.